PhenomeX Inc. (Nasdaq: CELL), relating to its proposed sale to Bruker Corp. Under the terms of the agreement, CELL shareholders will receive $1.00 in cash per share they own.
PhenomeX Inc. (Nasdaq: CELL), relating to its proposed sale to Bruker Corp. Under the terms of the agreement, CELL shareholders will receive $1.00 in cash per share they own.